Novel Immunotherapeutic Approaches in Head and Neck Cancer

Unresectable recurrent or metastatic head and neck cancer is an incurable disease with survival of approximately 12 months. Head and neck tumors exhibit numerous derangements in the tumor microenvironment that aid in immune evasion and may serve as targets for future therapies. Pembrolizumab is now...

Full description

Saved in:
Bibliographic Details
Published in:J Cancer Metastasis Treat
Main Authors: Heft Neal, ME, Haring, CT, Mann, JE, Brenner, JC, Spector, ME, Swiecicki, PL
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7357897/
https://ncbi.nlm.nih.gov/pubmed/32661502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/2394-4722.2019.32
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items